Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The impact of initial highly active antiretroviral therapy on future treatment sequences in HIV infection.

AIDS (London, England) - 24 Sept 2004

Klein Marina B, Willemot Patrick, Murphy Tanya, Lalonde Richard G

Abstract excerpt

OBJECTIVES: To determine whether the initial use of non-nucleoside reverse transcriptase inhibitors (NNRTI) or protease inhibitors (PI) differentially influences subsequent HIV therapy. DESIGN: A cohort study using a prospective clinical database in a university-based HIV clinic. SUBJECTS: A total of 440 HIV-seropositive patients, naive or nucleoside experienced, initiating therapy with either an NNRTI or PI...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiretroviral Therapy, Highly Active
Share to CD4 Lymphocyte Count

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Resistance, Multiple, Viral

Share to HIV Infections

Share to HIV Protease Inhibitors

Share to HIV Seropositivity

Share to Reverse Transcriptase Inhibitors

Share to Salvage Therapy

Source

Identifiers

PMID: 15353975
DOI: 10.1097/00002030-200409240-00005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The impact of initial highly active antiretroviral therapy on future treatment sequences in HIV infection.PMID 15353975Read ↗

Long-term consequences of the delay between virologic failure of highly active antiretroviral therapy and regimen modificationSemantic proximity Read ↗

Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection.Semantic proximity Read ↗

Interruption of treatment with individual therapeutic drug classes in adults with multidrug-resistant HIV-1 infection.Semantic proximity Read ↗

Factors associated with the successful modification of antiretroviral therapy. HIV Outpatient Study Investigators.Semantic proximity Read ↗

Treatment history and baseline viral load, but not viral tropism or CCR-5 genotype, influence prolonged antiviral efficacy of highly active antiretroviral treatment.Semantic proximity Read ↗

Tenofovir treatment in an unselected cohort of highly antiretroviral experienced HIV positive patients.Semantic proximity Read ↗

Effect of HIV-1 subtype on virologic and immunologic response to starting highly active antiretroviral therapy.Semantic proximity Read ↗

Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudineSemantic proximity Read ↗

Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection.Semantic proximity Read ↗

Management of antiretroviral therapy for HIV infection: modelling when to change therapy.Semantic proximity Read ↗

Factors associated with virological response to etravirine in nonnucleoside reverse transcriptase inhibitor-experienced HIV-1-infected patients.Semantic proximity Read ↗

Efavirenz- and adefovir dipivoxil-based salvage therapy in highly treatment-experienced patients: clinical and genotypic predictors of virologic response.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.